SPC516
Atezolizumab
Status:
UmsóknApplication date:
9.6.2025Application published:
1.7.2025
Medicine name:
TecentriqMedicine for children:
Yes
Timeline
Today
9.6.2025Application
1.7.2025Publication
Marketing license
IS authorization number:
EU/1/17/1220Date:
5.10.2017
Foreign authorization number:
EU/1/17/1220Date:
21.9.2017
Owner
Name:
F. Hoffmann-La Roche AGAddress:
Grenzacherstrasse 124, 4070 Basel CH
Agent
Name:
Örn Þór slf.Address:
Klukkuvöllum 17, 221 Hafnarfirði
Patent
Number:
EP4331604